We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Examines clinical outcomes of apalutamide in high-risk localized prostate cancer, suggesting potential survival benefits.
No takes yet. Share an insight, caveat, or question.
Taplin et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: